NIH-funded research NIH-funded research

Understanding how cells sense nutrients and regulate metabolism

Official title: Molecular Mechanisms of Organelle-based Metabolic Signaling

Funded at University of California Berkeley · NIH-11074674 · Data updated 2026-11-12

This study is looking at how a special protein in our cells helps them sense nutrients and manage energy, which could lead to better treatments for conditions like type-2 diabetes and cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California Berkeley
NIH-funded
Lab location1 site (Berkeley, United States)
Project startMay 1, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$614,394
NIH project number5R35GM149302-03
Project IDNIH-11074674 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with adult-onset diabetes or metabolic disorders related to nutrient sensing.

Less likely to help

Patients with metabolic conditions unrelated to mTORC1 signaling may not benefit from this research.

What this research studies

This research investigates the molecular mechanisms by which cells detect nutrients and regulate their metabolism, focusing on a key protein kinase called mTORC1. By examining how mTORC1 is activated in response to various metabolic signals, including nutrients and energy levels, the research aims to uncover insights into metabolic regulation in both healthy and diseased states. The study employs advanced techniques to explore the interactions between mTORC1 and cellular organelles, particularly lysosomes, which play a crucial role in nutrient sensing. The findings could lead to new therapeutic strategies for conditions like type-2 diabetes and cancer.

Why it matters

Potential benefit: If successful, this research could lead to novel treatments for metabolic disorders and cancers by targeting the pathways involved in nutrient sensing.

How similar studies have gone: Previous research has shown promising results in understanding mTORC1 signaling, indicating that this approach has potential for significant breakthroughs.

Where this research is happening

  • University of California Berkeley
    Berkeley, United States
    Active

Researchers

  • Principal investigator: Zoncu, Roberto — University of California Berkeley
  • Study coordinator: Zoncu, Roberto

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.